Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • symptoms88 symptoms88 Sep 9, 2013 2:37 PM Flag

    MTSL re ISIS

    ..."also of interest, recent reports say that Merck has asked Gilead for a 10% royalty on the potential blockbuster sofobuvir of which ISIS would receive approx 20% (or 2% royalty). A favorable ruling could unlock a material royalty stream for ISIS, which could be worth as much as $7/share for ISIS." ...

    Sentiment: Strong Buy

 
ISIS
57.560.00(0.00%)Dec 21 4:00 PMEST